Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer.
P. Saip
No relevant relationships to disclose
Y. Eralp
No relevant relationships to disclose
M. Ozkan
No relevant relationships to disclose
H. Karaca
No relevant relationships to disclose
M. Benekli
No relevant relationships to disclose
B. Cetin
No relevant relationships to disclose
A. Isikdogan
No relevant relationships to disclose
M. Kucukoner
No relevant relationships to disclose
G. Basaran
No relevant relationships to disclose
F. Sen
No relevant relationships to disclose
O. Un
No relevant relationships to disclose
H. Onur
No relevant relationships to disclose